Investigating the Potential of Nilotinib and its Derivatives in Targeting Tau Protein Hyperphosphorylation for Alzheimer's Disease Treatment
Mathews Journal of Pharmaceutical Science · 2023
DOI: 10.30654/mjps.10025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mathews Journal of Pharmaceutical Science, 2023. Verfasst von Aria Hajihassan und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hajihassan, A., Zandi, A., Esmaeili, G., & Norizadeh, M. (2023). Investigating the Potential of Nilotinib and its Derivatives in Targeting Tau Protein Hyperphosphorylation for Alzheimer's Disease Treatment. Mathews Journal of Pharmaceutical Science. https://doi.org/10.30654/mjps.10025
Vancouver
Hajihassan A, Zandi A, Esmaeili G, Norizadeh M. Investigating the Potential of Nilotinib and its Derivatives in Targeting Tau Protein Hyperphosphorylation for Alzheimer's Disease Treatment. Mathews Journal of Pharmaceutical Science. 2023. doi:10.30654/mjps.10025
BibTeX
@article{Hajihassan2023,
author = {Hajihassan, Aria and Zandi, Atena and Esmaeili, Ghazal and Norizadeh, Mostafa},
title = {Investigating the Potential of Nilotinib and its Derivatives in Targeting Tau Protein Hyperphosphorylation for Alzheimer's Disease Treatment},
journal = {Mathews Journal of Pharmaceutical Science},
year = {2023},
doi = {10.30654/mjps.10025}
}
EUVIMED